Home/Filings/4/0001209191-23-023944
4//SEC Filing

Robbins Wendye 4

Accession 0001209191-23-023944

CIK 0001673772other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 8:07 PM ET

Size

5.9 KB

Accession

0001209191-23-023944

Insider Transaction Report

Form 4
Period: 2023-03-31
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-31$14.52/sh+3,616$52,5043,616 total
    Exercise: $18.35Exp: 2033-03-30Common Stock (3,616 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2023 with the first installment vesting on March 31, 2023, provided that the reporting person is in service as a director on each such vesting date.
  • [F2]This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $52,500.

Issuer

RAPT Therapeutics, Inc.

CIK 0001673772

Entity typeother

Related Parties

1
  • filerCIK 0001791244

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 8:07 PM ET
Size
5.9 KB